Abstract Introduction: Anti-Müllerian hormone (AMH) is widely used as a marker of ovarian reserve and is also incorporated into the diagnostic assessment of polyendocrine metabolic ovarian syndrome (PMOS). Although PMOS is strongly associated with metabolic dysfunction and abnormal adipose tissue distribution, the relationship between AMH concentrations and adiposity, and especially visceral adiposity remains unclear.
Julia Herman
Get in touch with Julia
Contact Julia, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack